Global Hospital Care Partnering 2014 to 2021 provides the full collection of Hospital Care disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014.
Trends in Hospital Care partnering deals Financial deal terms for headline, upfront and royalty by stage of development Hospital Care partnering agreement structure Hospital Care partnering contract documents Top Hospital Care deals by value Most active Hospital Care dealmakers
Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor’s product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.
The report takes readers through the comprehensive Hospital Care disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Hospital Care deals.
The report presents financial deal terms values for Hospital Care deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.
The initial chapters of this report provide an orientation of Hospital Care dealmaking trends.
Chapter 1 provides an introduction to the report.
Chapter 2 provides an overview of the trends in Hospital Care dealmaking since 2014 covering trends by year, deal type, stage of development, technology type and therapeutic indication.
Chapter 3 includes an analysis of financial deal terms covering headline value, upfront payment, milestone payments and royalty rates.
Chapter 4 provides a review of the leading Hospital Care deals since 2014. Deals are listed by headline value. The chapter includes the top 25 most active Hospital Care dealmakers, together with a full listing of deals to which they are a party. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.
Chapter 5 provides comprehensive access to Hospital Care deals since 2014 where a deal contract is available, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink to an online version of the deal record contract document, providing easy access to each contract document on demand.
Chapter 6 provides a comprehensive directory of all Hospital Care partnering deals by specific Hospital Care target announced since 2014. The chapter is organized by specific Hospital Care therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
In addition, a comprehensive appendix is provided with each report of all Hospital Care partnering deals signed and announced since 2014. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
The report also includes numerous tables and figures that illustrate the trends and activities in Hospital Care partnering and dealmaking since 2014.
In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Hospital Care technologies and products.
Report scope Global Hospital Care Partnering 2014 to 2021 is intended to provide the reader with an in-depth understanding and access to Hospital Care trends and structure of deals entered into by leading companies worldwide.
Global Hospital Care Partnering 2014 to 2021 includes: Trends in Hospital Care dealmaking in the biopharma industry since 2014 Access to headline, upfront, milestone and royalty data Access to hundreds of Hospital Care deal contract documents Comprehensive access to over 1200 Hospital Care deal records The leading Hospital Care deals by value since 2014 Most active Hospital Care dealmakers since 2014
The report includes deals for the following indications: Accident and emergency, Rehabilitation medicine, Surgery, Orthopedics, Aesthetic procedures, Transplantation, plus other Hospital Care indications.
In Global Hospital Care Partnering 2014 to 2021, available deals and contracts are listed by: Headline value Upfront payment value Royalty rate value Stage of development at signing Deal component type Technology type Specific therapy indication
Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
The Global Hospital care Partnering 2014-2021 report provides comprehensive access to available deals and contract documents for over 1200 hospital care deals. Analyzing actual contract agreements allows assessment of the following: • What are the precise rights granted or optioned? • What is actually granted by the agreement to the partner company? • What exclusivity is granted? • What is the payment structure for the deal? • How are the sales and payments audited? • What is the deal term? • How are the key terms of the agreement defined? • How are IPRs handled and owned? • Who is responsible for commercialization? • Who is responsible for development, supply, and manufacture? • How is confidentiality and publication managed? • How are disputes to be resolved? • Under what conditions can the deal be terminated? • What happens when there is a change of ownership? • What sublicensing and subcontracting provisions have been agreed? • Which boilerplate clauses does the company insist upon? • Which boilerplate clauses appear to differ from partner to partner or deal type to deal type? • Which jurisdiction does the company insist upon for agreement law?
Our reports have been used by over 10K customers, including:
U.S. Patient Positioning Systems Market Size, Share & Trends Analysis Report By Product (Tables, Accessories), By Application (Surgery, Diagnostics), By End-use (Hospitals, Ambulatory Surgical Centers), And Segment Forecasts, 2022 - 2030 U.S. Patient Positioning Systems Market Growth & Trends The...
The global biological safety testing market reached a value of US$ 3.51 Billion in 2021. Looking forward, the analyst expects the market to reach US$ 7.16 Billion by 2027, exhibiting at a CAGR of 12.55% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect...
392 pages •
By Global Industry Analysts
• Feb 2022
Abstract: What`s New for 2022? -Global competitiveness and key competitor percentage market shares -Market presence across multiple geographies - Strong/Active/Niche/Trivial -Online interactive peer-to-peer collaborative bespoke updates -Access to our digital archives and MarketGlass...
Abstract Medical Device Manufacturing in China Firms in the Medical Device Manufacturing industry in China manufacture medical diagnosis equipment, medical monitoring equipment and medical treatment equipment. Firms in this industry purchase materials (such as metals, plastics, parts and components)...
The global scintillator market reached a value of US$ 512.3 Million in 2021. Looking forward, the analyst expects the market to reach US$ 687.3 Million by 2027, exhibiting at a CAGR of 4.9% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence...
The Latin America, Middle East and Africa Gene Synthesis Market would witness market growth of 21.1% CAGR during the forecast period (2021-2027). An artificial gene is a human-made replacement of the cell-free protein synthesis of double-stranded DNA molecules. This technology is widely used in the biotechnology sector and crucial for...
350 pages •
By The Business Research Company
• Feb 2022
Major companies in the ambulance services market include American Medical Response, Inc., Providence Service Corporation, Falck AS, Air Methods Corporation, Fresenius Medical Care AG & Co. KGaA, Acadian Ambulance Service, Inc. and NHS England. The global ambulance services market is expected to decline from $60.35 billion in 2021 to...
175 pages •
By The Business Research Company
• Feb 2022
Major players in the fertility services market are Merck KGaA, Care Fertility, INVO Bioscience, Vitrolife, Monash IVF Group, Carolinas Fertility Institute, IntegraMed, Inc., New Hope Fertility Center and Apollo Hospitals Enterprise Ltd. The global fertility services market is expected to grow from $40.73 billion in 2021 to $47.17 billion...
Helping hands: The outbreak of COVID-19 has increased industry funding and revenue Abstract Crisis and Care Accommodation in Australia The industry provides residential care accommodation (except aged care) combined with nursing, supervisory or other types of care as required (including...
Housing
Health Services
Nursing Home
Hospital
Caring Services
Specialty Hospital
Respite Care
Financial Services
Australia
Employment Income
Unemployment Rate
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.